Denmark· DK-28105842916
Lamzede
A velmanase alfa product containing velmanase alfa, registered in Denmark by Chiesi Farmaceutici S.p.a.. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Velmanase alfa is registered in 12 of 19 countries.
Countries holding a registration under ATC A16AB15 (velmanase alfa), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Velmanase alfa · ATC A16AB15
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Velmanase alfa
- Manufacturer
- Chiesi Farmaceutici S.p.a.
- Country
- Denmark (DK)
- ATC code
- A16AB15
- ATC class
- Velmanase alfa
- Defined daily dose
- 10 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105842916
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A16AB15
Velmanase alfa, as other registers publish it.
- FinlandLamzedeChiesi Farmaceutici S.p.A.
- PolandLamzedeChiesi Farmaceutici S.p.A.
- IcelandLamzedeChiesi Farmaceutici S.p.A.*
- NorwayLamzedeChiesi Farmaceutici S.p.a.
- CzechiaLAMZEDEChiesi Farmaceutici S.p.A., Parma
- CzechiaLAMZEDEChiesi Farmaceutici S.p.A., Parma
- CzechiaLAMZEDEChiesi Farmaceutici S.p.A., Parma
- BelgiumLamzede 10 mgChiesi Farmaceutici
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/821ec3eb-ca15-4688-a330-47ceb062f85a GET /v1/drugs/821ec3eb-ca15-4688-a330-47ceb062f85a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til infusionsvæske, opløsning",
"source": "dkma",
"strength": "10 mg",
"auth_role": "MOD",
"dk_drugid": "28105842916",
"substance": "Velmanase alfa",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43182"
}See everything about velmanase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.